Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Potential First FDA-approved Therapy for Treatment of Molluscum Contagiosum Prevalence of Over 6 Million Molluscum…
Month: January 2023
Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions
Pricing Provides VENDAJETM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA., Jan. 24, 2023 (GLOBE…
Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
iSpecimen Appoints Eric Langlois as Chief Revenue Officer
Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company’s…
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
Psyence and Eden Labs Announce Extraction and Product Development Collaboration
TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG. |. OTCQB: PSYGF)…
Tonix Pharmaceuticals Announces Publication of Paper in Antiviral Research Highlighting the Company’s Development of Monoclonal Antibody Therapeutics for Monkeypox and Smallpox
Data Represent Research and Development Work Being Conducted at Tonix’s Infectious Disease R&D Center (RDC)…
First Wave BioPharma to Present at Sequire Biotechnology Conference
BOCA RATON, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First…
Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO
The CTA authorization for DB-OTO provides approval for the Company to expand its planned Phase…
CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
NEWARK, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage…
PolyPid Provides Positive Regulatory Update for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
• Regulatory Pathway for a Potential NDA Submission Clarified Following Recent Interactions with the FDA • FDA…
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
Company Announcement Net sales of DARZALEX® in 2022 totaled USD 7,977 million Genmab receives royalties…
Cellebrite Enterprise Solutions 2023 Industry Trends Report Finds 70 Percent of eDiscovery Professionals State Accessing Data Offsite Is a Major Endpoint Collection Problem
Hybrid work causing major data collection headaches for eDiscovery professionals, slowing down corporate fraud, IP…
Cobwebs Technologies Partners with All Things Possible to Fight Human Trafficking
NEW YORK, NY, Jan. 24, 2023 (GLOBE NEWSWIRE) — Cobwebs Technologies, a global leader in…
LaunchDarkly Federal Becomes the First FedRAMP-Authorized Feature Management Platform
U.S. Government Agencies Now Able to Deliver Software Faster and Improve Security of Releases OAKLAND,…
Survey Says: Medicare Members want Brain Health Programs
SAN FRANCISCO, Jan. 24, 2023 (GLOBE NEWSWIRE) — Seniors want proven brain health programs included…
Nozomi Networks Innovates to Deliver the Industry’s First OT and IoT Endpoint Security Sensor
Nozomi Arc improves operational resiliency by significantly extending visibility across endpoint attack surfaces, dramatically reducing…
ICBM Expo – International Crypto Blockchain and Metaverse Expo Dubai
ICBM Expo – The Nucleus of Game Changing Technologies Dubai, United Arab Emirates–(Newsfile Corp. –…
Online Yoga School Launches 50-Hour Pranayama Teacher Training and Breathwork Certification
San Antonio, Texas–(Newsfile Corp. – January 24, 2023) – Digital yoga platform pioneer Online Yoga…
Cognetivity Neurosciences’ CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer’s Patients Receiving Disease-Modifying Therapy
Demonstrable sensitivity and clinical usability of Cognetivity’s screening and monitoring tool leaves the company well…